Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-40.92%
0%
-40.92%
6 Months
-54.07%
0%
-54.07%
1 Year
-72.01%
0%
-72.01%
2 Years
-81.77%
0%
-81.77%
3 Years
-97.51%
0%
-97.51%
4 Years
-98.3%
0%
-98.3%
5 Years
-98.57%
0%
-98.57%
Gensight Biologics SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
3.54%
EBIT Growth (5y)
10.33%
EBIT to Interest (avg)
-18.86
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.42
Sales to Capital Employed (avg)
0.03
Tax Ratio
7.31%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.61
EV to EBIT
-2.08
EV to EBITDA
-2.16
EV to Capital Employed
-1.80
EV to Sales
33.23
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
1.30
2.60
-50.00%
Operating Profit (PBDIT) excl Other Income
-28.40
-29.10
2.41%
Interest
3.20
3.00
6.67%
Exceptional Items
6.80
2.50
172.00%
Consolidate Net Profit
-26.20
-27.60
5.07%
Operating Profit Margin (Excl OI)
-24,776.60%
-11,664.60%
-1,311.20%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -50.00% vs -50.94% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 5.07% vs 3.50% in Dec 2022
About Gensight Biologics SA 
Gensight Biologics SA
Pharmaceuticals & Biotechnology
Gensight Biologics SA is a France-based biopharmaceutical company. The Company develops and commercializes gene therapy-based treatments of retinal degenerative diseases. It develops approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from low vision or blindness. The Company intends notably to develop a gene replacement therapy for Leber's hereditary optic neuropathy (LHON) and an optogenetic therapy for retinitis pigmentosa (RP).
Company Coordinates 
Company Details
74 rue du Faubourg Saint Antoine , PARIS None : 75012
Registrar Details






